Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00410891 · ClinicalTrials.gov registry record · Phase 4

Topical Antibiotics and Intravitreous Injections

A Phase 4 study, sponsored by Stanford University.

Completed
Registry status
Phase 4
Development phase
129
Enrollment target

NCT00410891: Completed Phase 4 study, sponsored by Stanford University.

NCT00410891 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 129 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00410891, a Phase 4 study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
Phase 4
Development phase
129 participants
Enrollment target

Study Summary

Evaluation of efficacy of topical preoperative antibiotics in patients undergoing intravitreous injections.

Primary Outcome

The percentage of patients with a positive bacterial culture following administration of study treatment is presented.

Interventions

  • DRUG gatifloxacin

Trial Details

FieldValue
Enrollment Target 129 participants
Start Date 2008-07
Est. Completion 2009-12
Phase Phase 4
Stanford University

1,744 total trials

What the finished NCT00410891 record still lists

NCT00410891 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% lower).

The record links to 0 conditions, and to 1 intervention - of which gatifloxacin is the first listed.

NCT00410891 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00410891 about?

NCT00410891 is a clinical study titled "Topical Antibiotics and Intravitreous Injections". Evaluation of efficacy of topical preoperative antibiotics in patients undergoing intravitreous injections.

What is the current status of trial NCT00410891?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 129 participants. The study started on 2008-07. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00410891?

The interventions under investigation include: gatifloxacin (DRUG).

Who is sponsoring clinical trial NCT00410891?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00410891's enrollment target sits among peer trials

129 631st of 2000 higher than 1,367 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03619850 · 129 participants · Phase 3

    A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

  • NCT05704361 · 129 participants · Phase 1

    A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis

  • NCT05919849 · 129 participants · Phase 1

    Supporting Parents in Affirming Their Children's Experiences of Stigma

  • NCT06313749 · 129 participants · NA

    Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00410891, the US trial registry maintained by the National Library of Medicine. NCT00410891 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.